Reported Standalone quarterly numbers for Suven Life Sciences are:Net Sales at Rs 4.43 crore in December 2021 up 192.99% from Rs. 1.51 crore in December 2020.
Quarterly Net Loss at Rs. 8.22 crore in December 2021 down 0.88% from Rs. 8.15 crore in December 2020.
EBITDA stands negative at Rs. 6.87 crore in December 2021 up 21.49% from Rs. 8.75 crore in December 2020.
Suven Life Sci shares closed at 89.05 on January 28, 2022 (NSE) and has given 7.16% returns over the last 6 months and 19.85% over the last 12 months.
| Suven Life Sciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'21 | Sep'21 | Dec'20 | | Net Sales/Income from operations | 4.43 | 1.18 | 1.51 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 4.43 | 1.18 | 1.51 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.10 | 4.21 | 3.80 | | Depreciation | 1.22 | 1.03 | 1.14 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | 6.02 | 7.30 | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 7.34 | 1.26 | 0.78 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -8.23 | -11.34 | -11.51 | | Other Income | 0.14 | 0.50 | 1.62 | | P/L Before Int., Excpt. Items & Tax | -8.09 | -10.83 | -9.89 | | Interest | 0.13 | 0.15 | 0.17 | | P/L Before Exceptional Items & Tax | -8.22 | -10.98 | -10.05 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -8.22 | -10.98 | -10.05 | | Tax | -- | -- | -1.91 | | P/L After Tax from Ordinary Activities | -8.22 | -10.98 | -8.15 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -8.22 | -10.98 | -8.15 | | Equity Share Capital | 12.73 | 12.73 | 12.73 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.65 | -0.86 | -0.64 | | Diluted EPS | -0.65 | -0.86 | -0.64 | | EPS After Extra Ordinary | | Basic EPS | -0.65 | -0.86 | -0.64 | | Diluted EPS | -0.65 | -0.86 | -0.64 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
